Efficacy and Tolerability of Moxifloxacin in Patients with Respiratory Tract Infections Treated in General Practice: Results of a Post-Marketing Surveillance Study

By Chen Weiqiang   Wu Changgui   Li Zhikui   Bai Changqing  

Clinical Drug Investigation, Vol. 26, Iss. 9, 2006-01 ,pp. : 501-509

Adis International

Access to resources Recommend Favorite

Efficacy and Tolerability of Sequential Intravenous/Oral Moxifloxacin Therapy in Pneumonia: Results of the First Post-Marketing Surveillance Study with Intravenous Moxifloxacin in Hospital Practice

By Barth J.  

Clinical Drug Investigation, Vol. 25, Iss. 11, 2005-01 ,pp. : 691-700

Adis International

Access to resources Recommend Favorite

Efficacy, Onset of Action and Tolerability of Moxifloxacin in Patients with Community-Acquired Pneumonia: Results of a Postmarketing Surveillance Study

By Landen H.  

Clinical Drug Investigation, Vol. 21, Iss. 12, 2001-12 ,pp. : 801-811

Adis International

Access to resources Recommend Favorite

Once-Daily Moxifloxacin Therapy for Community-Acquired Pneumonia in General Practice: Evidence from a Post-Marketing Surveillance Study of 1467 Patients

By H. Koch  

Clinical Drug Investigation, Vol. 24, Iss. 8, 2004-01 ,pp. : 441-448

Adis International

Access to resources Recommend Favorite

Postmarketing Surveillance Study of the Efficacy and Tolerability of Pioglitazone in Insulin-Resistant Patients with Type 2 Diabetes Mellitus in General Practice

By Schöfl C.  

Clinical Drug Investigation, Vol. 23, Iss. 11, 2003-01 ,pp. : 725-734

Adis International

Access to resources Recommend Favorite